Prognosis
J&J Raises EU Concern With Plan to Package Vaccines in U.S.
- Details on manufacturing plan disclosed in EU diplomatic note
- Some countries concerned it could lead to more vaccine delays
This article is for subscribers only.
Johnson & Johnson will ship some Covid-19 vaccines ordered by the European Union to the U.S. for the last stage of production, raising concern among some member states that the bloc’s inoculation program could be hampered by further delays, according to a diplomatic note seen by Bloomberg.
EU ambassadors were told at a briefing last Wednesday that the pharmaceutical company will send a portion of the vaccine produced in Europe to the U.S. for what’s known as fill and finish. In that stage, the shot is put into vials, packaged and shipped for distribution.